Interview with Marten Siemelink and me on the DNA-poli platform (www.dan-poli.nl) an online platform to inform at risk relatives of index patients with #cardiomyopathies. We hope to submit the data of the RCT later in 2026 emea01.safelinks.protection.outlook.com?url=http%3A%...
TLI is proud to welcome Michelle L. Matter, PhD, whose expertise in #cardiomyopathies, sepsis, and cellular signaling will strengthen our research in #cardiovascular medicine.
Join us in celebrating her arrival and the exciting scientific impact ahead!🔬Learn about Dr. Matter's work: bit.ly/4jp8b6c
New research calls for a standardized approach to #TTN variant interpretation and deeper investigation into missing heritability in individuals with heterozygous TTNtv. bit.ly/4qgLW5k #titinopathies #cardiomyopathies #neuromusculardisorders
Super productive time at the
@americanheart.bsky.social Scientific Sessions Meeting in New Orleans! We presented one of our recent projects on mechanisms of troponin desensitization #cardiovasculardisease #AHA25 #HCM #HeartFailure #Cardiomyopathies
Magnetic resonance imaging of #cardiomyopathies in #children: Update by the European Society of Pediatric Radiology Cardiac Imaging Taskforce link.springer.com/article/10.1... #hvhebron #rad
DNA-poli is a digital platform to digitalize the cascade genetic testing process in cardiogenetics. An RCT will test its potential to boost uptake while matching the quality of standard care. bit.ly/46hDdrY #GIMO #DigitalHealth #GeneticCarrierScreening #Cardiomyopathies
📣 Metabolic #cardiomyopathies: untangling clinical heterogeneity with human #StemCell derived models
By A. Passadouro, @rhhoutkooper.bsky.social, S. Mosegaard & colleagues at University of Amsterdam
➡️ doi.org/10.1038/s443...
Thrilled to share that our abstract has been accepted at the 2025 @americanheart.bsky.social Scientific Sessions Meeting in New Orleans! We hope to see you there on Sunday🫀🔬 #AHA25 #AmericanHeartAssociation #Cardiomyopathies #HeartDisease
Three enrichment categories not observed in MIS-C were identified: #cardiomyopathies, #carbohydratemetabolism, & #serine-type peptidase activity. This finding aligns with the known impact of pre-existing heart conditions on #COVID outcomes,
Genetic testing in #cardiomyopathies and new therapeutic target in cardiac remodelling
academic.oup.com/eurheartj/ar...
#CardioEd #CMP @escardio.bsky.social @jennkwanmdphd.bsky.social @pnatarajanmd.bsky.social @cardioobdoc.bsky.social
ACTU AP-HM • Un nouveau centre de référence à l’Hôpital de la Timone : le Centre de Référence des Cardiomyopathies. fr.ap-hm.fr/actu/nouveau... #APHM #Cardiomyopathies #Santé #Marseille #InnovationMédicale
